SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-107874
Filing Date
2019-04-16
Accepted
2019-04-16 16:30:36
Documents
4
Period of Report
2019-05-21
Effectiveness Date
2019-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d678494ddef14a.htm DEF 14A 557368
2 GRAPHIC g678494dsp001.jpg GRAPHIC 159897
3 GRAPHIC g678494dsp002.jpg GRAPHIC 106725
4 GRAPHIC g678494g05k91.jpg GRAPHIC 41803
  Complete submission text file 0001193125-19-107874.txt   975176
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37766 | Film No.: 19751309
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences